Efficacy of continuing pembrolizumab after progression on first-line treatment in stage IV non-small cell lung cancer: a prospective real-world study
一线治疗进展后继续使用帕博利珠单抗治疗IV期非小细胞肺癌的疗效:一项前瞻性真实世界研究
期刊:American Journal of Cancer Research
影响因子:2.9
doi:10.62347/GFTO6440
Ruan, Kexin; Lv, Xiaodong; Wu, Xiaoyu; Shao, Jingjing; Chen, Peifeng; Sun, Debin; Tang, Yaodong; Wang, Bin; Ding, Yongmin; Han, Zhiqiang; Huang, Weina; Wu, Dan; Xu, Youzu; Zheng, Jing; Qu, Jingjing; Zhou, Jianya; Zhou, Jianying